Advances in sustainable building technology
TORONTO, Oct 4 2021 /PRNewswire/ – Control Technologies Corp. (NEO: KNR) (OTCQB: KNRLF) (FSE: 1K8) (“Check” or the “Business“), a leader in smart building technologies, has received a first BioCloud order, following the signing of a Memorandum of Understanding (“MOU“) with an international heating, cooling and ventilation system (“HVAC operation“) On September 21NS, 2021. Kontrol and the HVAC Company continue to work towards a definitive distribution agreement and the potential of international manufacturing. The HVAC company is part of a large global industrial conglomerate that designs, manufactures and distributes its own products through more than 30,000 distributors worldwide.
The Steelcase distributor launch is scheduled for mid-October. To date, initial training, marketing materials and product pages have been prepared. Steelcase is a leading office technology solutions company and trades on the NYSE.
BioCloud will be showcased in Washington, DC with Marshall Communications to support meetings and presentations to various governments and USA military officials 11 Octobere, 2021.
“In a short space of time, BioCloud has grown into a recognized air quality brand and as we launch with or strategic distribution and scale partners, we look forward to being part of the solution for creating safer spaces,” said Paul Ghezzi, CEO of Control.
Carbon Credit Platform
Following the launch of its carbon credit platform, the company has received strong feedback from the market and is actively seeking opportunities in: Ontario, Quebec, Alberta and British Colombia just like the Eastern United States. Regions where energy costs are high and where local utilities offer incentive discounts for energy savings are ideal markets.
“With a growing portfolio of technology solutions to address the key challenges our customers face, including energy management, lower greenhouse gas emissions and improved air quality for the built environment, we are well positioned to further execute on our strategic vision,” continued Ghezzi .
About Kontrol BioCloudTM
BioCloud Control (“BioCloud“) is an operating subsidiary of Kontrol Technologies Corp. The BioCloud technology is a real-time analyzer designed to detect viruses and pathogens in the air. BioCloud is an air quality technology and not a medical device. BioCloud is designed to work as a safe space technology by continuously sampling air quality. With a patented detection chamber that can be replaced if necessary, viruses are detected and a silent notification system is created. BioCloud can be applied to any room where individuals gather. Additional information about Kontrol BioCloud can can be found on its website at www.kontrolbiocloud.com
About Kontrol Technologies Corp.
Control Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE: 1K8) is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol offers a combination of software, hardware and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Neither IIROC nor any stock exchange or other securities regulatory authority assumes any responsibility for the suitability or accuracy of this press release.
This press release contains “forward-looking information” within the meaning of applicable securities laws. Any statements contained herein that are not clearly historical in nature may contain forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may,” “will,” “expect,” “probably,” “would,” “would,” “plan,” “anticipate,” “intent.” “, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or circumstances “may” or “will” happen , or through discussions about strategy.
Where Kontrol expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have reasonable grounds. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that the technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking
explanations. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained or cannot be obtained on reasonable terms; that those technologies will not prove as effective as expected; those customers and potential customers will not accept the Company’s product and service offerings as expected; and governmental and regulatory factors affecting the energy-saving industry. control BioCloud is an air quality technology and not a medical device. The company makes no express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 coronavirus).
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as of the date of this publication and are based on management’s beliefs, estimates, expectations and opinions as of that date. Kontrol assumes no obligation to publicly update or revise such forward-looking statements or forward-looking statements in other documents, whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent events. and such forward-looking information, except as required under applicable securities laws. Readers are cautioned to carefully consider these and other factors, uncertainties and possible events and not to place undue reliance on forward-looking information.
SOURCE Kontrol Technologies Corp.